Exhibit 99.1
VaxGen, Inc.
CONSOLIDATED BALANCE SHEETS
(in thousands)
Unauditied
CONSOLIDATED BALANCE SHEETS
(in thousands)
Unauditied
January 31, | ||||
2009 | ||||
ASSETS | ||||
Current assets: | ||||
Cash and cash equivalents | $ | 32,941 | ||
Investment securities | 4,931 | |||
Accounts receivable | — | |||
Prepaid expenses and other current assets | 697 | |||
Assets held for sale | 780 | |||
Total current assets | 39,349 | |||
Restricted cash | 1,556 | |||
Other assets | 421 | |||
Total assets | $ | 41,326 | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
Current liabilities: | ||||
Accounts payable | $ | 115 | ||
Accrued and other current liabilities | 693 | |||
Total current liabilities | 808 | |||
Deferred rent and other liabilities | 4,596 | |||
Total liabilities | 5,404 | |||
Stockholders’ equity: | ||||
Common stock | 331 | |||
Additional paid-in capital | 302,856 | |||
Accumulated deficit | (267,547 | ) | ||
Accumulated other comprehensive income | 282 | |||
Total stockholders’ equity | 35,922 | |||
Total liabilities and stockholders’ equity | $ | 41,326 | ||